<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We present a patient with severe idiopathic <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> with no previous chromosomal abnormalities who developed <z:mp ids='MP_0004027'>trisomy</z:mp> 21 and <z:mp ids='MP_0004026'>monosomy</z:mp> 7 during treatment with intravenous (i.v.) <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>The abnormal karyotype disappeared when the drug was changed to the oral form </plain></SENT>
<SENT sid="2" pm="."><plain>This cytogenetic aberration, previously unreported in association with <z:chebi fb="0" ids="4031">cyclosporine</z:chebi>, may reflect either a direct drug effect or the emergence of a hidden myelodysplastic cell clone subject to preferential survival during immunosuppression </plain></SENT>
</text></document>